New Jersey S 1051: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone under certain conditions.

Status: Introduced in the Senate, Referred to Senate Commerce Committee (as of 2016-02-08)

State: New Jersey · Session: 217 · Bill: S 1051

Subjects: HEALTH INSUR, PHARMACEUTIC

Sponsors: Vitale, Joseph F., Weinberg, Loretta

View New Jersey S 1051 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.